on november 20, the forum was held in the global meeting hall of shenzhen university. it was co-organized by invest shenzhen, the shenzhen municipal public health and family planning commission, nanshan district government, march of dimes birth defects foundation of china, tongji university school of medicine, shenzhen university school of medicine and the china hongrui group. wu yihuan, shenzhen's deputy mayor warmly welcomed and addressed the gathering.
more than 300 chinese nationals, foreign experts and senior executives from across the life and health fields and industries attended. professor craig mello (nobel prize winner in physiology or medicine in 2006), professor gao guangping, director of the university of massachusetts gene therapy center, wei yuquan academician and vice-president of sichuan university, professor wang xiaoning, president of the elder disease research institute of the beijing people's liberation army hospital 301, and dr. chen poujian, ceo of the china hongrui group exchanged opinions and views on the development trends of the cutting-edge life and health-care technologies, challenges and opportunities in the industry, the latest academic and research achievements, and shared pertinent information. during the meeting, invest shenzhen introduced shenzhen’s outstanding business environment, supportive policies for the health care industry, and enormous investment and business opportunities, which drew close attention and deep interest among the gathering. the meeting was covered by a group of influential media agencies including the shenzhen special zone daily, shenzhen economic daily and www.sznews.com.
the life and health-care industry is one of the key industries in shenzhen. speeding up the development of the industry is significant to grasp opportunities in the latest round of scientific and technological breakthroughs, realize stable economic growth, and help build shenzhen into a modern, international and innovation-driven city. over recent years, invest shenzhen has continued tracking industry development and investment trends and has introduced a group of competitive companies, products and teams, including the team led by bernard roizman (academician from the university of chicago), the university college of london tumor treatment team, and the bupa global treatment center project. these organizations will definitely provide fresh fuel for innovation and growth of the industry.
